Pneumonia. Pneumonia in other diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: 4 cc Eucalyptus 5% with 6 mL of normal saline through the nebulizer kit every 8 hours daily during 20 to 30 minutes is given. Intervention 2: Control group: 10 mL o
Prevention
Placebo
Intervention group: 4 cc Eucalyptus 5% with 6 mL of normal saline through the nebulizer kit every 8 hours daily during 20 to 30 minutes is given.
Control group: 10 mL of sterile water via nebulizer kits inspired every 8 hours daily during 20 to 30 minutes is given.
Sponsors
Vice chancellor for research,Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the study included: not having lung infections and lung disease on admission, avoiding the use of immunosuppressive drugs, aged 40 to 70 years, not having sensitivity to Eucalyptus examining case histories and their relatives, patients intubated less than 6 hours, Not taking of antibiotics , No history of diabetes, level of consciousness (GCS) 3 to 8 Exclusion criteria: patient transport, hemodynamic disorders, liver complications, occurrence of urticaria, petechiae, itch and allergy symptoms eucalyptus, extubation and mortality
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ventilator Associated Pneumonia. Timepoint: Before and after the intervention. Method of measurement: CPIS measure. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRasool Kaviannezhad
Kermanshah university of medical sciences
Outcome results
None listed